Low specific gravity syndrome.
D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D002118:Calcium / Q000652:urine; D002712:Chlorides / Q000652:urine; D002908:Chronic Disease; D003404:Creatinine / Q000097:blood / Q000652:urine; D004827:Epilepsy / Q000097:blood / Q000652:urine*; D005260:Female; D006801:Humans; D008607:Intellectual Disability / Q000652:urine; D008297:Male; D008403:Mass Screening; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D009994:Osmolar Concentration; D010634:Phenobarbital / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011188:Potassium / Q000652:urine; D012964:Sodium / Q000652:urine; D013046:Specific Gravity; D013997:Time Factors; D014508:Urea / Q000097:blood / Q000652:urine; D014556:Urine / Q000032:analysis*; D014667:Vasopressins / Q000097:blood; D014882:Water-Electrolyte Balance
D000927:Anticonvulsants; D002712:Chlorides; D014667:Vasopressins; D010672:Phenytoin; D014508:Urea; D012964:Sodium; D003404:Creatinine; D011188:Potassium; D002118:Calcium; D010634:Phenobarbital